KLP Kapitalforvaltning’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$77.1M Buy
153,703
+6,680
+5% +$3.21M 0.25% 69
2026
Q1
$72.3M Buy
147,023
+4,200
+3% +$2.28M 0.28% 61
2025
Q4
$82.8M Buy
142,823
+440
+0.3% +$249K 0.32% 54
2025
Q3
$69.1M Sell
142,383
-300
-0.2% -$140K 0.27% 61
2025
Q2
$57.9M Buy
142,683
+5,600
+4% +$2.34M 0.25% 73
2025
Q1
$68.3M Buy
137,083
+1,800
+1% +$975K 0.33% 52
2024
Q4
$70.4M Buy
+135,283
New +$74.4M 0.33% 45

Other funds holding TMO

KLP Kapitalforvaltning's TMO Position: Q2 2026 in Review

KLP Kapitalforvaltning increased its Thermo Fisher Scientific (TMO) stake by 4.5% in Q2 2026, buying an estimated $3.21M and bringing the position to 153,703 shares worth $77.1M. The position accounts for 0.25% of the portfolio, ranked #69.

KLP Kapitalforvaltning first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. The position peaked at $82.8M in Q4 2025. 2,602 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • KLP Kapitalforvaltning held 153,703 shares of Thermo Fisher Scientific worth $77.1M as of Q2 2026.
  • KLP Kapitalforvaltning bought 6,680 Thermo Fisher Scientific shares in Q2 2026, an estimated $3.21M.
  • Thermo Fisher Scientific made up 0.25% of KLP Kapitalforvaltning's portfolio in Q2 2026, its #69 holding.
  • KLP Kapitalforvaltning first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • KLP Kapitalforvaltning's Thermo Fisher Scientific position peaked at $82.8M in Q4 2025.
  • 2,602 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q2 2026, filed 12 Aug 2026.